Episode
This Doctor Left Conventional Medicine to Transform Cancer Care—Here’s What He Discovered
- Podcast
- Metabolic Matters
- Published
- May 27, 2025
- Duration seconds
- 3652
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/metabolic-matters-6612088/episodes/this-doctor-left-conventional-medicine-to-transform-cancer-care-here-s-what-he-discovered/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/metabolic-matters-6612088/this-doctor-left-conventional-medicine-to-transform-cancer-care-here-s-what-he-discovered.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this thought-provoking and heartfelt episode of Metabolic Matters , host Dr. Nasha Winters welcomes Dr. Nathan Goodyear, a leading voice in integrative oncology and a passionate advocate for patient-centered cancer care. Dr. Goodyear shares his extraordinary journey from conventional OB/GYN pelvic floor surgery to becoming a pioneer in metabolic and integrative cancer therapies. Through personal experience, clinical insights, and a steadfast commitment to innovation, he explores how the landscape of oncology is transforming toward precision, empowerment, and healing. Key Topics: From Surgeon to Integrative Oncologist: Dr. Goodyear recounts his early career in pelvic floor surgery and the pivotal moments—including his own health crisis—that catalyzed his shift into integrative medicine. Redefining Healing: A deeply personal conversation on what it means to “heal into dying,” featuring reflections on end-of-life care, patient autonomy, and the emotional realities of oncology. The Future of Cancer Therapies: Microbiome & Fecal Transplants : Why the tumor microbiome might be a game-changing biomarker—and therapeutic target—for cancer. Cannabinoid Medicine : Exploring the anti-cancer potential of CBD, the stigma around cannabis, and its immunological implications. Immune Modulation & Vitamin C : Highlighting high-dose IV vitamin C, LDN, and strategies to enhance immune surveillance. Repurposed Medications: Dr. Goodyear discusses the growing momentum behind off-label drug use in cancer care, including ivermectin and propranolol, and the critical need for bridging conversations between conventional and integrative oncologists. Bridging Paradigms: A passionate call for collaboration across disciplines to dismantle silos and build patient-centered, innovation-driven…